These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2476893)

  • 1. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.
    Neurath AR; Seto B; Strick N
    Vaccine; 1989 Jun; 7(3):234-6. PubMed ID: 2476893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus surface antigen (HBsAg) as carrier for synthetic peptides having an attached hydrophobic tail.
    Neurath AR; Strick N; Girard M
    Mol Immunol; 1989 Jan; 26(1):53-62. PubMed ID: 2467197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.
    Neurath AR; Kent SB; Strick N; Parker K; Courouce AM; Riottot MM; Petit MA; Budkowska A; Girard M; Pillot J
    Mol Immunol; 1987 Sep; 24(9):975-80. PubMed ID: 3657811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
    Neurath AR; Kent SB; Parker K; Prince AM; Strick N; Brotman B; Sproul P
    Vaccine; 1986 Mar; 4(1):35-7. PubMed ID: 2421497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.
    Zhang J; Wang Q; Yuan W; Li J; Yuan Q; Zhang J; Xia N; Wang Y; Li J; Tong S
    J Virol; 2024 Aug; 98(8):e0192923. PubMed ID: 39078152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).
    Petit MA; Dubanchet S; Capel F; Voet P; Dauguet C; Hauser P
    Virology; 1991 Feb; 180(2):483-91. PubMed ID: 1703368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies recognizing human serum albumin are not elicited by immunization with preS2 sequences of the hepatitis B virus envelope protein.
    Neurath AR; Strick N; Parker K; Kent SB
    J Med Virol; 1988 Feb; 24(2):137-51. PubMed ID: 3351483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Dobrica MO; Lazar C; Paruch L; van Eerde A; Clarke JL; Tucureanu C; Caras I; Ciulean S; Onu A; Tofan V; Branzan A; Urban S; Stavaru C; Branza-Nichita N
    Vaccine; 2018 Sep; 36(38):5789-5795. PubMed ID: 30082163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R; Kawano T; Kang JH; Murata M
    World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.
    Neurath AR; Kent SB; Adamowicz P; Riottot MM; Price P; Strick N; Parker K; Petit MA; Budkowska A; Girard M
    Mol Immunol; 1987 Jun; 24(6):561-8. PubMed ID: 3657796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus.
    Petit MA; Dubanchet S; Capel F
    Mol Immunol; 1989 Jun; 26(6):531-7. PubMed ID: 2475766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.
    Barnaba V; Franco A; Alberti A; Balsano C; Benvenuto R; Balsano F
    J Immunol; 1989 Oct; 143(8):2650-5. PubMed ID: 2477450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
    Cornelius C; Schöneweis K; Georgi F; Weber M; Niederberger V; Zieglmayer P; Niespodziana K; Trauner M; Hofer H; Urban S; Valenta R
    EBioMedicine; 2016 Sep; 11():58-67. PubMed ID: 27568223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus.
    Yato K; Matsuda M; Fukano K; Tanaka T; Moriishi K; Nishitsuji H; Shimotohno K; Tamura K; Wakita T; Muramatsu M; Kato T; Suzuki R
    Virus Res; 2023 Jan; 323():199014. PubMed ID: 36511290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
    Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
    J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.
    Ferrari C; Penna A; Bertoletti A; Cavalli A; Valli A; Schianchi C; Fiaccadori F
    J Clin Invest; 1989 Oct; 84(4):1314-9. PubMed ID: 2529268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.